Cargando…

The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review

Several risk factors for Coronavirus-2019 (COVID-19) disease have been highlighted in clinical evidence. Among the various risk factors are advanced age, metabolic illness such as diabetes, heart disease, and diseases of the respiratory system. Cystic Fibrosis (CF) is a rare disease with autosomal r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitiello, Antonio, Sabbatucci, Michela, Silenzi, Andrea, Capuano, Annalisa, Rossi, Francesco, Zovi, Andrea, Blasi, Francesco, Rezza, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644493/ https://www.ncbi.nlm.nih.gov/pubmed/37957647 http://dx.doi.org/10.1186/s12931-023-02593-1

Ejemplares similares

Childhood Immunisation Coverage during the COVID-19 Epidemic in Italy
por: Sabbatucci, Michela, et al.
Publicado: (2022)

Omicron variant evolution on vaccines and monoclonal antibodies
por: Sabbatucci, Michela, et al.
Publicado: (2023)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Antifungal Drug Resistance: An Emergent Health Threat
por: Vitiello, Antonio, et al.
Publicado: (2023)

Improved Temporal Trends of Vaccination Coverage Rates in Childhood after the Mandatory Vaccination Act, Italy 2014–2019
por: Sabbatucci, Michela, et al.
Publicado: (2021)

Cystic fibrosis drug ivacaftor stimulates CFTR channels at picomolar concentrations
por: Csanády, László, et al.
Publicado: (2019)

Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)

New emerging SARS-CoV-2 variants and antiviral agents
por: Vitiello, A., et al.
Publicado: (2023)

Scoping Review on Barriers and Challenges to Pediatric Immunization Uptake among Migrants: Health Inequalities in Italy, 2003 to Mid-2023
por: Sana, Samina, et al.
Publicado: (2023)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2017)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
por: Moliteo, Evelina, et al.
Publicado: (2022)

CFTR modulators: transformative therapies for cystic fibrosis
por: Dwight, Mary, et al.
Publicado: (2021)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN STATE CHANNEL MODELS
por: Corradi, Valentina, et al.
Publicado: (2015)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

The direct correlation between microbiota and SARS-CoV-2 infectious disease
por: Vitiello, Antonio, et al.
Publicado: (2023)

A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR
por: Liu, Jia, et al.
Publicado: (2022)

Locating the Anion-selectivity Filter of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel
por: Cheung, Min, et al.
Publicado: (1997)

The Mechanistic Links between Insulin and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl(−) Channel
por: Marunaka, Yoshinori
Publicado: (2017)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Fixing cystic fibrosis by correcting CFTR domain assembly
por: Okiyoneda, Tsukasa, et al.
Publicado: (2012)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Lived experiences of individuals with cystic fibrosis on CFTR-modulators
por: Page, Annelise, et al.
Publicado: (2022)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Nutritional impact of CFTR modulators in children with cystic fibrosis
por: Gaschignard, Margaux, et al.
Publicado: (2023)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
por: Dobi, Dorina, et al.
Publicado: (2023)

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): THREE-DIMENSIONAL STRUCTURE AND LOCALIZATION OF A CHANNEL GATE
por: Rosenberg, Mark F., et al.
Publicado: (2011)

Cystic fibrosis transmembrane conductance regulator (CFTR): Making an ion channel out of an active transporter structure
por: Linsdell, Paul
Publicado: (2018)

Nirmatrelvir–remdesivir association for non-hospitalized adults with COVID-19, point of view
por: Ferrara, Francesco, et al.
Publicado: (2022)

Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological Therapies
por: Vitiello, Antonio, et al.
Publicado: (2022)

Pharmacological Agents with Antiviral Activity against Monkeypox Infection
por: Zovi, Andrea, et al.
Publicado: (2022)

Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions
por: Vitiello, Antonio, et al.
Publicado: (2022)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
por: Fukuda, Ryosuke, et al.
Publicado: (2020)

What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials
por: Di Napoli, Raffaella, et al.
Publicado: (2023)

Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis
por: Chanoux, Rebecca A., et al.
Publicado: (2012)

Predicting CFTR activity with front-runner cystic fibrosis drugs
por: Becq, Frédéric
Publicado: (2015)

The importance of CFTR expression for neutrophil function in patients with Cystic Fibrosis
por: Jundi, B, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r2ntomsqtebia6ptrvqvgorsqm